The Dana-Farber Cancer Institute at Londonderry
Londonderry, New Hampshire, United States
Cancer treatment center in Londonderry, New Hampshire
40 Buttrick Rd STE B, Londonderry, NH 03053
About The Dana-Farber Cancer Institute at Londonderry
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Dana-Farber Cancer Institute
16
Alliance for Clinical Trials in Oncology
10
National Cancer Institute (NCI)
9
Alliance Foundation Trials, LLC.
1
Canadian Cancer Trials Group
1
ECOG-ACRIN Cancer Research Group
1
Clinical Trials at The Dana-Farber Cancer Institute at Londonderry
During the past decade, The Dana-Farber Cancer Institute at Londonderry conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 17 clinical trials were completed, i.e. on
average, 85% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 12 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
2004-01-01
2014-10-01
Completed
645
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
2008-10-13
2017-06-15
Completed
799
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
2009-07-15
2021-06-15
Completed
506
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
2010-02-01
2018-03-01
Terminated
313
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
2010-06-25
2022-07-31
Completed
3,649
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Dana-Farber Cancer Institute at Londonderry" #1 sponsor was "Dana-Farber Cancer Institute" with 16 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials
sponsored, "National Cancer Institute (NCI)" with 9 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored and "Canadian Cancer Trials Group"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Dana-Farber Cancer Institute at Londonderry"
#1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Ambry Genetics" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at The Dana-Farber Cancer Institute at Londonderry
According to Clinical.Site data, the most researched conditions in "The Dana-Farber Cancer Institute at Londonderry" are
"Breast Cancer" (13 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials) and "Breast Ductal Carcinoma In Situ" (2 trials). Many other conditions were trialed in "The Dana-Farber Cancer Institute at Londonderry" in a lesser frequency.
Clinical Trials Intervention Types at The Dana-Farber Cancer Institute at Londonderry
Most popular intervention types in "The Dana-Farber Cancer Institute at Londonderry" are "Drug" (29 trials), "Other" (20 trials), "Biological" (7 trials), "Dietary Supplement" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (6 trials), "Questionnaire Administration" (5 trials) and "Clinical Observation" (4 trials). Other intervention names were less common.
Clinical Trials Genders at The Dana-Farber Cancer Institute at Londonderry
The vast majority of trials in "The Dana-Farber Cancer Institute at Londonderry" are
30 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at The Dana-Farber Cancer Institute at Londonderry
Currently, there are NaN active trials in "The Dana-Farber Cancer Institute at Londonderry".
undefined are not yet recruiting,
9 are recruiting,
15 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in The Dana-Farber Cancer Institute at Londonderry,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in The Dana-Farber Cancer Institute at Londonderry, 0 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".